Skip to main content
. 2022 Dec 12;44(6):1161–1174. doi: 10.1038/s41401-022-01031-0

Fig. 8. Schematic diagram showing the mechanism of intramuscularly-injected empagliflozin in enhancing therapeutic angiogenesis.

Fig. 8

Empagliflozin inhibits hyperglycemia-induced ferroptosis in skeletal muscle cells by enhancing GPX4 expression, thus promoting revascularization in diabetic HLI mice.